BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30215611)

  • 41. Development of Microfluidic Systems Enabling High-Throughput Single-Cell Protein Characterization.
    Fan B; Li X; Chen D; Peng H; Wang J; Chen J
    Sensors (Basel); 2016 Feb; 16(2):232. PubMed ID: 26891303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Materials for microfluidic chip fabrication.
    Ren K; Zhou J; Wu H
    Acc Chem Res; 2013 Nov; 46(11):2396-406. PubMed ID: 24245999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrogel Droplet Microfluidics for High-Throughput Single Molecule/Cell Analysis.
    Zhu Z; Yang CJ
    Acc Chem Res; 2017 Jan; 50(1):22-31. PubMed ID: 28029779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives: the second Symposium on Innovative Polymers for Controlled Delivery Suzhou, China, 11–14 September 2012 .
    Feijen J; Hennink WE; Zhong Z
    Nanomedicine (Lond); 2013 Feb; 8(2):177-80. PubMed ID: 23394154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanomedicine: de novo design of nanodrugs.
    Yang Z; Kang SG; Zhou R
    Nanoscale; 2014 Jan; 6(2):663-77. PubMed ID: 24305636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microfluidic impedance flow cytometry enabling high-throughput single-cell electrical property characterization.
    Chen J; Xue C; Zhao Y; Chen D; Wu MH; Wang J
    Int J Mol Sci; 2015 Apr; 16(5):9804-30. PubMed ID: 25938973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic efficacy of nanomedicines for prostate cancer: An update.
    Lakshmanan VK
    Investig Clin Urol; 2016 Jan; 57(1):21-9. PubMed ID: 26966723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoferritin applications in nanomedicine.
    Heger Z; Skalickova S; Zitka O; Adam V; Kizek R
    Nanomedicine (Lond); 2014 Jul; 9(14):2233-45. PubMed ID: 25405799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. More than Just Size: Challenges and Opportunities of Hybrid Dendritic Nanocarriers.
    Rimondino GN; Oksdath-Mansilla G; Brunetti V; Strumia MC
    Curr Pharm Des; 2017; 23(21):3142-3153. PubMed ID: 28403793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoassays in microfluidic systems.
    Ng AH; Uddayasankar U; Wheeler AR
    Anal Bioanal Chem; 2010 Jun; 397(3):991-1007. PubMed ID: 20422163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metal-Organic Framework-Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging.
    Cai W; Chu CC; Liu G; Wáng YX
    Small; 2015 Oct; 11(37):4806-22. PubMed ID: 26193176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale.
    das Neves J; Bahia MF; Amiji MM; Sarmento B
    Expert Opin Drug Deliv; 2011 Aug; 8(8):1085-104. PubMed ID: 21599564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microfluidic platforms for plant cells studies.
    Sanati Nezhad A
    Lab Chip; 2014 Sep; 14(17):3262-74. PubMed ID: 24984591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments in microfluidics-based chemotaxis studies.
    Wu J; Wu X; Lin F
    Lab Chip; 2013 Jul; 13(13):2484-99. PubMed ID: 23712326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of microfluidic chips in the simulation of the urinary system microenvironment.
    Hou C; Gu Y; Yuan W; Zhang W; Xiu X; Lin J; Gao Y; Liu P; Chen X; Song L
    Mater Today Bio; 2023 Apr; 19():100553. PubMed ID: 36747584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.